Phase I/II Trials of Silymarin for Chronic Liver Diseases
The summary for the Phase I/II Trials of Silymarin for Chronic Liver Diseases grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Phase I/II Trials of Silymarin for Chronic Liver Diseases: - This RFA is a one-time solicitation to request for applications to perform multi-site Phase I/II clinical trials of silymarin for liver diseases. - The anticipated number of awards to be funded is 5, which will include 4 awards for Clinical Sites and 1 award for a Data Coordinating Center (DCC). - The total amount to be awarded for all work (clinical trials and DCC combined) is $5,000,000-$6,000,000. - The type of mechanism is U01. - Eligible organizations include for-profit or non-profit organizations, public or private institutions (e.g., universities, colleges, hospitals), units of state and local governments, eligible agencies of the Federal government, domestic institutions, and faith-based or community-based organizations. - Eligible principal investigators include any individual with the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are encouraged to apply for NIH programs. - The number of applications each applicant may submit is 1. Applications for a Clinical Site and the Data Coordinating Center may come from a single Institution, but the Principal Investigators on the two applications must be different persons. - See Section IV.1 for application materials. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088
| Federal Grant Title: | Phase I/II Trials of Silymarin for Chronic Liver Diseases |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health Food and Nutrition |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-AT-05-006 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.21393.848 |
| CFDA Descriptions: | Research and Training in Complementary and Alternative Medicine 93.848 Digestive Diseases and Nutrition Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Sep 12, 2005 |
| Posted Date: | Jun 07, 2005 |
| Creation Date: | Jun 07, 2005 |
| Archive Date: | Oct 12, 2005 |
| Total Program Funding: | $5,000,000 |
| Maximum Federal Grant Award: | $600,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 5 |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are not eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster